[English] 日本語
Yorodumi
- PDB-8s9a: Crystal structure of the TYK2 pseudokinase domain in complex with... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 8s9a
TitleCrystal structure of the TYK2 pseudokinase domain in complex with TAK-279
ComponentsNon-receptor tyrosine-protein kinase TYK2
KeywordsTRANSFERASE / TYK2 / pseudokinase / JH2 / immunology
Function / homology
Function and homology information


type III interferon-mediated signaling pathway / interleukin-10-mediated signaling pathway / interleukin-12 receptor complex / interleukin-23 receptor complex / interleukin-23-mediated signaling pathway / Interleukin-23 signaling / positive regulation of T-helper 17 type immune response / interleukin-12-mediated signaling pathway / positive regulation of NK T cell proliferation / Interleukin-12 signaling ...type III interferon-mediated signaling pathway / interleukin-10-mediated signaling pathway / interleukin-12 receptor complex / interleukin-23 receptor complex / interleukin-23-mediated signaling pathway / Interleukin-23 signaling / positive regulation of T-helper 17 type immune response / interleukin-12-mediated signaling pathway / positive regulation of NK T cell proliferation / Interleukin-12 signaling / IL-6-type cytokine receptor ligand interactions / Interleukin-27 signaling / Interleukin-35 Signalling / growth hormone receptor binding / extrinsic component of cytoplasmic side of plasma membrane / Other interleukin signaling / extrinsic component of plasma membrane / Interleukin-20 family signaling / Interleukin-6 signaling / type I interferon-mediated signaling pathway / MAPK3 (ERK1) activation / MAPK1 (ERK2) activation / Interleukin-10 signaling / positive regulation of interleukin-17 production / positive regulation of natural killer cell proliferation / Regulation of IFNA/IFNB signaling / growth hormone receptor signaling pathway via JAK-STAT / cell surface receptor signaling pathway via JAK-STAT / type II interferon-mediated signaling pathway / Signaling by CSF3 (G-CSF) / positive regulation of T cell proliferation / positive regulation of receptor signaling pathway via JAK-STAT / non-membrane spanning protein tyrosine kinase activity / Inactivation of CSF3 (G-CSF) signaling / Evasion by RSV of host interferon responses / non-specific protein-tyrosine kinase / cellular response to virus / positive regulation of protein localization to nucleus / cytoplasmic side of plasma membrane / Interferon alpha/beta signaling / positive regulation of type II interferon production / Signaling by ALK fusions and activated point mutants / cytokine-mediated signaling pathway / protein tyrosine kinase activity / Interleukin-4 and Interleukin-13 signaling / Potential therapeutics for SARS / cell differentiation / cytoskeleton / cell population proliferation / receptor complex / intracellular signal transduction / protein phosphorylation / immune response / SARS-CoV-2 activates/modulates innate and adaptive immune responses / extracellular exosome / ATP binding / nucleus / plasma membrane / cytosol / cytoplasm
Similarity search - Function
Tyrosine-protein kinase, non-receptor, TYK2, N-terminal / Tyrosine-protein kinase, non-receptor Jak/Tyk2 / JAK, FERM F2 lobe domain / FERM F1 lobe ubiquitin-like domain / JAK1-3/TYK2, pleckstrin homology-like domain / : / Jak1 pleckstrin homology-like domain / FERM F2 acyl-CoA binding protein-like domain / FERM F1 ubiquitin-like domain / SH2 domain ...Tyrosine-protein kinase, non-receptor, TYK2, N-terminal / Tyrosine-protein kinase, non-receptor Jak/Tyk2 / JAK, FERM F2 lobe domain / FERM F1 lobe ubiquitin-like domain / JAK1-3/TYK2, pleckstrin homology-like domain / : / Jak1 pleckstrin homology-like domain / FERM F2 acyl-CoA binding protein-like domain / FERM F1 ubiquitin-like domain / SH2 domain / FERM superfamily, second domain / FERM domain / FERM domain profile. / Band 4.1 domain / Band 4.1 homologues / Src homology 2 domains / SH2 domain / SH2 domain superfamily / Tyrosine-protein kinase, catalytic domain / Tyrosine kinase, catalytic domain / Tyrosine protein kinases specific active-site signature. / Tyrosine-protein kinase, active site / Serine-threonine/tyrosine-protein kinase, catalytic domain / Protein tyrosine and serine/threonine kinase / Phosphorylase Kinase; domain 1 / Phosphorylase Kinase; domain 1 / Transferase(Phosphotransferase) domain 1 / Transferase(Phosphotransferase); domain 1 / Protein kinase, ATP binding site / Protein kinases ATP-binding region signature. / Protein kinase domain profile. / Protein kinase domain / Protein kinase-like domain superfamily / 2-Layer Sandwich / Orthogonal Bundle / Mainly Alpha / Alpha Beta
Similarity search - Domain/homology
ACETATE ION / Chem-ZSB / Non-receptor tyrosine-protein kinase TYK2
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 1.83 Å
AuthorsToms, A.V. / Leit, S. / Greenwood, J.R. / Carriero, S. / Mondal, S. / Abel, R. / Ashwell, M. / Blanchette, H. / Boyles, N. / Cartwright, M. ...Toms, A.V. / Leit, S. / Greenwood, J.R. / Carriero, S. / Mondal, S. / Abel, R. / Ashwell, M. / Blanchette, H. / Boyles, N. / Cartwright, M. / Collis, A. / Feng, S. / Ghanakota, P. / Harriman, G.C. / Hosagrahara, V. / Kaila, N. / Kapeller, R. / Rafi, S. / Romero, D.L. / Tarantino, P. / Timaniya, J. / Wester, R.T. / Westlin, W. / Srivastava, B. / Miao, W. / Tummino, P. / McElwee, J.J. / Edmondson, S.D. / Massee, C.E.
Funding support1items
OrganizationGrant numberCountry
Not funded
CitationJournal: J.Med.Chem. / Year: 2023
Title: Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279.
Authors: Leit, S. / Greenwood, J. / Carriero, S. / Mondal, S. / Abel, R. / Ashwell, M. / Blanchette, H. / Boyles, N.A. / Cartwright, M. / Collis, A. / Feng, S. / Ghanakota, P. / Harriman, G.C. / ...Authors: Leit, S. / Greenwood, J. / Carriero, S. / Mondal, S. / Abel, R. / Ashwell, M. / Blanchette, H. / Boyles, N.A. / Cartwright, M. / Collis, A. / Feng, S. / Ghanakota, P. / Harriman, G.C. / Hosagrahara, V. / Kaila, N. / Kapeller, R. / Rafi, S.B. / Romero, D.L. / Tarantino, P.M. / Timaniya, J. / Toms, A.V. / Wester, R.T. / Westlin, W. / Srivastava, B. / Miao, W. / Tummino, P. / McElwee, J.J. / Edmondson, S.D. / Masse, C.E.
History
DepositionMar 27, 2023Deposition site: RCSB / Processing site: RCSB
Revision 1.0Jul 26, 2023Provider: repository / Type: Initial release
Revision 1.1Aug 23, 2023Group: Data collection / Database references
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / citation / citation_author
Item: _citation.journal_volume / _citation.page_first ..._citation.journal_volume / _citation.page_first / _citation.page_last / _citation_author.identifier_ORCID

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Non-receptor tyrosine-protein kinase TYK2
B: Non-receptor tyrosine-protein kinase TYK2
C: Non-receptor tyrosine-protein kinase TYK2
hetero molecules


Theoretical massNumber of molelcules
Total (without water)101,50225
Polymers98,9653
Non-polymers2,53722
Water10,737596
1
A: Non-receptor tyrosine-protein kinase TYK2
hetero molecules


Theoretical massNumber of molelcules
Total (without water)33,93610
Polymers32,9881
Non-polymers9489
Water181
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
MethodPISA
2
B: Non-receptor tyrosine-protein kinase TYK2
hetero molecules


Theoretical massNumber of molelcules
Total (without water)33,6916
Polymers32,9881
Non-polymers7035
Water181
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
MethodPISA
3
C: Non-receptor tyrosine-protein kinase TYK2
hetero molecules


Theoretical massNumber of molelcules
Total (without water)33,8749
Polymers32,9881
Non-polymers8868
Water181
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
MethodPISA
Unit cell
Length a, b, c (Å)48.222, 112.940, 157.348
Angle α, β, γ (deg.)90.00, 90.00, 90.00
Int Tables number19
Space group name H-MP212121

-
Components

#1: Protein Non-receptor tyrosine-protein kinase TYK2


Mass: 32988.441 Da / Num. of mol.: 3
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: TYK2 / Production host: Spodoptera frugiperda (fall armyworm)
References: UniProt: P29597, non-specific protein-tyrosine kinase
#2: Chemical ChemComp-ZSB / (8S)-N-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5-{[(1P,2'P)-2-oxo-2H-[1,2'-bipyridin]-3-yl]amino}pyrazolo[1,5-a]pyrimidine-3-carboxamide / TAK-279


Mass: 460.488 Da / Num. of mol.: 3 / Source method: obtained synthetically / Formula: C23H24N8O3 / Feature type: SUBJECT OF INVESTIGATION
#3: Chemical
ChemComp-ACT / ACETATE ION


Mass: 59.044 Da / Num. of mol.: 8 / Source method: obtained synthetically / Formula: C2H3O2
#4: Chemical
ChemComp-EDO / 1,2-ETHANEDIOL / ETHYLENE GLYCOL


Mass: 62.068 Da / Num. of mol.: 11 / Source method: obtained synthetically / Formula: C2H6O2
#5: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 596 / Source method: isolated from a natural source / Formula: H2O
Has ligand of interestY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.16 Å3/Da / Density % sol: 43.18 %
Crystal growTemperature: 298 K / Method: vapor diffusion
Details: The purified protein was used in crystallization trials employing both, a standard screen with approximately 1200 different conditions, as well as crystallization conditions identified using ...Details: The purified protein was used in crystallization trials employing both, a standard screen with approximately 1200 different conditions, as well as crystallization conditions identified using literature data. Conditions initially obtained have been optimized using standard strategies, systematically varying parameters critically influencing crystallization, such as temperature, protein concentration, drop ratio, and others. These conditions were also refined by systematically varying pH or precipitant concentrations

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: SLS / Beamline: X10SA / Wavelength: 1 Å
DetectorType: DECTRIS PILATUS 6M / Detector: PIXEL / Date: Jul 12, 2018
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1 Å / Relative weight: 1
ReflectionResolution: 1.83→91.75 Å / Num. obs: 74066 / % possible obs: 96.1 % / Redundancy: 2.9 % / Rrim(I) all: 0.067 / Rsym value: 0.055 / Net I/σ(I): 15.93
Reflection shellResolution: 1.83→2.08 Å / Redundancy: 2.9 % / Mean I/σ(I) obs: 2.97 / Num. unique obs: 23317 / Rrim(I) all: 0.514 / Rsym value: 0.421 / % possible all: 96.1

-
Processing

Software
NameVersionClassification
REFMAC5.8.0267refinement
XSCALEdata scaling
XDSdata reduction
PHASERphasing
RefinementMethod to determine structure: MOLECULAR REPLACEMENT / Resolution: 1.83→45.92 Å / Cor.coef. Fo:Fc: 0.959 / Cor.coef. Fo:Fc free: 0.941 / SU B: 6.675 / SU ML: 0.101 / Cross valid method: THROUGHOUT / ESU R: 0.14 / ESU R Free: 0.132 / Stereochemistry target values: MAXIMUM LIKELIHOOD / Details: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS
RfactorNum. reflection% reflectionSelection details
Rfree0.22398 2388 3.2 %RANDOM
Rwork0.18488 ---
obs0.18614 71595 96.37 %-
Solvent computationIon probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: MASK
Displacement parametersBiso mean: 25.003 Å2
Baniso -1Baniso -2Baniso -3
1--0.86 Å20 Å2-0 Å2
2--1.24 Å2-0 Å2
3----0.38 Å2
Refinement stepCycle: 1 / Resolution: 1.83→45.92 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms6242 0 178 596 7016
Refine LS restraints
Refine-IDTypeDev idealDev ideal targetNumber
X-RAY DIFFRACTIONr_bond_refined_d0.0080.0136662
X-RAY DIFFRACTIONr_bond_other_d0.0010.0156279
X-RAY DIFFRACTIONr_angle_refined_deg1.5051.6699044
X-RAY DIFFRACTIONr_angle_other_deg1.3741.58914438
X-RAY DIFFRACTIONr_dihedral_angle_1_deg6.3485816
X-RAY DIFFRACTIONr_dihedral_angle_2_deg31.16120.904343
X-RAY DIFFRACTIONr_dihedral_angle_3_deg12.576151076
X-RAY DIFFRACTIONr_dihedral_angle_4_deg17.9041555
X-RAY DIFFRACTIONr_chiral_restr0.0730.2831
X-RAY DIFFRACTIONr_gen_planes_refined0.0080.027525
X-RAY DIFFRACTIONr_gen_planes_other0.0020.021530
X-RAY DIFFRACTIONr_nbd_refined
X-RAY DIFFRACTIONr_nbd_other
X-RAY DIFFRACTIONr_nbtor_refined
X-RAY DIFFRACTIONr_nbtor_other
X-RAY DIFFRACTIONr_xyhbond_nbd_refined
X-RAY DIFFRACTIONr_xyhbond_nbd_other
X-RAY DIFFRACTIONr_metal_ion_refined
X-RAY DIFFRACTIONr_metal_ion_other
X-RAY DIFFRACTIONr_symmetry_vdw_refined
X-RAY DIFFRACTIONr_symmetry_vdw_other
X-RAY DIFFRACTIONr_symmetry_hbond_refined
X-RAY DIFFRACTIONr_symmetry_hbond_other
X-RAY DIFFRACTIONr_symmetry_metal_ion_refined
X-RAY DIFFRACTIONr_symmetry_metal_ion_other
X-RAY DIFFRACTIONr_mcbond_it0.8711.3883246
X-RAY DIFFRACTIONr_mcbond_other0.8471.3793236
X-RAY DIFFRACTIONr_mcangle_it1.5022.064062
X-RAY DIFFRACTIONr_mcangle_other1.5022.064063
X-RAY DIFFRACTIONr_scbond_it0.8961.5113416
X-RAY DIFFRACTIONr_scbond_other0.8961.5123417
X-RAY DIFFRACTIONr_scangle_it
X-RAY DIFFRACTIONr_scangle_other1.4852.2174977
X-RAY DIFFRACTIONr_long_range_B_refined5.25917.437550
X-RAY DIFFRACTIONr_long_range_B_other5.08616.7357407
X-RAY DIFFRACTIONr_rigid_bond_restr
X-RAY DIFFRACTIONr_sphericity_free
X-RAY DIFFRACTIONr_sphericity_bonded
LS refinement shellResolution: 1.83→1.878 Å / Total num. of bins used: 20
RfactorNum. reflection% reflection
Rfree0.378 181 -
Rwork0.332 5187 -
obs--96.29 %
Refinement TLS params.

Method: refined / Refine-ID: X-RAY DIFFRACTION

IDL11 (°2)L12 (°2)L13 (°2)L22 (°2)L23 (°2)L33 (°2)S11 (Å °)S12 (Å °)S13 (Å °)S21 (Å °)S22 (Å °)S23 (Å °)S31 (Å °)S32 (Å °)S33 (Å °)T11 (Å2)T12 (Å2)T13 (Å2)T22 (Å2)T23 (Å2)T33 (Å2)Origin x (Å)Origin y (Å)Origin z (Å)
12.1883-0.3588-0.5721.47960.46841.3739-0.01210.2968-0.1141-0.2332-0.03020.0476-0.0393-0.03910.04240.09340.001-0.02110.0423-0.02260.12681.007-38.32315.629
21.2198-0.1866-0.22842.34710.02191.1558-0.041-0.1983-0.12870.30770.0725-0.05680.16530.1495-0.03150.11360.0313-0.02310.0450.00590.13650.219-44.69338.151
32.7753-0.09880.65051.15560.05491.7853-0.0471-0.36210.12780.1860.00470.05550.0108-0.05980.04240.0828-0.00240.02340.0494-0.02750.1119-23.016-22.15940.004
41.06480.59530.20732.0267-0.44881.1657-0.05290.18670.0836-0.23270.0430.0214-0.11180.07930.00990.1049-0.01420.0110.0388-0.00230.1394-23.766-15.40317.403
51.7106-0.38230.38051.1501-0.38591.70690.07860.25390.0222-0.2276-0.0711-0.05730.08480.061-0.00740.12770.0230.01850.0392-0.00240.1189-29.204-79.012-13.461
61.0385-0.52040.17872.17630.15770.820.007-0.16960.09170.17050.0086-0.0289-0.0876-0.0724-0.01560.08930.00160.01780.0326-0.01160.127-28.886-68.4097.285
Refinement TLS group
IDRefine-IDRefine TLS-IDAuth asym-IDAuth seq-ID
1X-RAY DIFFRACTION1A577 - 689
2X-RAY DIFFRACTION2A690 - 868
3X-RAY DIFFRACTION3B578 - 689
4X-RAY DIFFRACTION4B690 - 867
5X-RAY DIFFRACTION5C578 - 689
6X-RAY DIFFRACTION6C690 - 867

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more